GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (NAS:PRTC) » Definitions » EV-to-Revenue

PureTech Health (PureTech Health) EV-to-Revenue : 668.40 (As of Jun. 05, 2024)


View and export this data going back to 2020. Start your Free Trial

What is PureTech Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, PureTech Health's enterprise value is $501.30 Mil. PureTech Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.75 Mil. Therefore, PureTech Health's EV-to-Revenue for today is 668.40.

The historical rank and industry rank for PureTech Health's EV-to-Revenue or its related term are showing as below:

PRTC' s EV-to-Revenue Range Over the Past 10 Years
Min: -8.97   Med: 100.44   Max: 696.78
Current: 668.4

During the past 12 years, the highest EV-to-Revenue of PureTech Health was 696.78. The lowest was -8.97. And the median was 100.44.

PRTC's EV-to-Revenue is ranked worse than
93.35% of 1038 companies
in the Biotechnology industry
Industry Median: 7.985 vs PRTC: 668.40

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-05), PureTech Health's stock price is $29.92. PureTech Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.03. Therefore, PureTech Health's PS Ratio for today is 1,108.15.


PureTech Health EV-to-Revenue Historical Data

The historical data trend for PureTech Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PureTech Health EV-to-Revenue Chart

PureTech Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 121.55 143.09 69.67 290.12 480.45

PureTech Health Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.67 - 290.12 - 480.45

Competitive Comparison of PureTech Health's EV-to-Revenue

For the Biotechnology subindustry, PureTech Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PureTech Health's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PureTech Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where PureTech Health's EV-to-Revenue falls into.



PureTech Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

PureTech Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=501.303/0.75
=668.40

PureTech Health's current Enterprise Value is $501.30 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PureTech Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PureTech Health  (NAS:PRTC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

PureTech Health's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=29.92/0.027
=1,108.15

PureTech Health's share price for today is $29.92.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was $0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PureTech Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of PureTech Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PureTech Health (PureTech Health) Business Description

Traded in Other Exchanges
Address
6 Tide Street, Suite 400, Boston, MA, USA, 02210
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

PureTech Health (PureTech Health) Headlines